Major Milestone For Melbourne-Based Drug Development Company The Latest Testament To Strength And Success Of Australia's Leading Biotechnology Sector
The State Government of Victoria, Australia announced the continued success of its thriving biotechnology industry, as evidenced by the recent news from Melbourne-based drug delivery company Acrux. The company announced last week that the United States Food and Drug Administration (FDA) approved its Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator. This major milestone is just the latest testament to the strength of Victoria's biotech sector... (Source: Health News from Medical News Today)
Researchers Develop New Brain Map
University of Georgia researchers have developed a map of the human brain that shows great promise as a new guide to the inner workings of the body's most complex and critical organ. With this map, researchers hope to create a next-generation brain atlas that will be an alternative option to the atlas created by German anatomist Korbinian Brodmann more than 100 years ago, which is still commonly used in clinical and research settings... (Source: Health News from Medical News Today)
